Legal Representation
Attorney
Norman P. Soloway
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 3, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jul 3, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jul 3, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Apr 24, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Apr 24, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Apr 24, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Apr 22, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 21, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 18, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer; Pharmaceuticals for the treatment of cancer; Chemicopharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for veterinary use for the treatment of cancer; Chemical preparations for pharmaceutical purposes for the treatment of cancer; Pharmaceutical preparations for human use for the treatment of cancer; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Diagnostic preparations for medical purposes; Diagnostic agents for pharmaceutical use; Diagnostic agents for medical use; Diagnostic preparations for veterinary purposes; Clinical diagnostic reagents; Diagnostic chemical reagents for medical use; Anticancer drugs; Compounds for treating cancer; Anti-cancer preparations; Anti-cancer preparations of chemical origin; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Chemotherapeutics; Antibodies for medical purposes; Antibody-drug conjugates for the treatment of cancer; Pharmaceutical preparations for immunotherapy
Class 042
Pharmaceutical research services; Medical and pharmacological research services; Pharmaceutical product development; Development of pharmaceutical preparations and medicines; Consultancy relating to pharmaceutical research and development; Provision of research services in the field of toxicology, stem cell and medical research; Scientific research; Medical research; Biomedical research services; Research relating to biotechnology; Research on the subject of pharmaceuticals; Consultancy relating to research in the field of pharmacogenetics; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of diagnostic preparations; Research and development in the field of biotechnology; Research and development for the pharmaceutical industry; Research and development services in the field of antibody technology; Research and development services in the field of antibodies and antibody-drug conjugates; Laboratory services relating to the production of monoclonal antibodies and antibody-drug conjugates
Class 044
Pharmaceutical services, namely, pharmaceutical compounding services in the field of oncology; Pharmaceutical advice; Pharmaceutical services, namely, pharmaceutical compounding services; Consultancy and information services relating to pharmaceutical products; Providing healthcare information regarding cancer drugs and cancer treatment
Classification
International Classes
005
042
044
USPTO Documents
Loading USPTO documents...